Logo
Whalesbook
HomeStocksNewsPremiumAbout UsContact Us

Infosys Stock Tumbles 15% YTD: Can AI Strategy and Favorable Valuation Spark a Turnaround?

Tech|5th December 2025, 4:49 AM
Logo
AuthorAkshat Lakshkar | Whalesbook News Team

Overview

Infosys reported Q2 FY26 revenue growth of 2.2% sequentially (Constant Currency) and revised its full-year guidance to 2-3%. Margins improved slightly to 21%, with guidance unchanged at 20-22%. Despite a soft outlook and year-to-date stock underperformance, the company is intensifying its focus on Enterprise AI and its Topaz suite. Favorable valuation suggests limited downside risk.

Infosys Stock Tumbles 15% YTD: Can AI Strategy and Favorable Valuation Spark a Turnaround?

Stocks Mentioned

Infosys Limited

Infosys, a leading IT services bellwether, has released its financial results for the second quarter of fiscal year 2026, revealing a mixed picture of modest growth alongside a strategic pivot towards Artificial Intelligence.

Key Financials and Guidance

  • Revenue Growth: The company reported a 2.2 percent sequential revenue growth in Constant Currency (CC) for Q2 FY26. Year-on-year growth for the first half of the fiscal year stood at 3.3 percent in CC.
  • Revised Outlook: Infosys has adjusted its full-year FY26 revenue growth guidance to 2-3 percent in Constant Currency, maintaining the upper end of its previous expectation. This recalibration, despite a decent first half and strong bookings, signals an anticipated softness in the second half, primarily due to seasonal factors like furloughs and fewer working days.
  • Margin Performance: Operating margins saw a sequential improvement of 20 basis points, reaching 21 percent in Q2. However, given the subdued H2 outlook, significant margin improvement is not expected for the remainder of the year. The FY26 margin guidance remains unchanged at 20-22 percent.

Deal Wins and AI Focus

  • Deal Pipeline: Large deal inflows were steady in Q2, with 23 deals signed, 67 percent of which were net new. This inflow saw a 24 percent year-on-year growth but was lower compared to the preceding quarter.
  • Mega Deal: A significant development announced post the end of Q2 was a $1.6 billion mega deal secured with the UK's National Health Service (NHS).
  • Enterprise AI Ambitions: Infosys is actively working towards becoming a leading Enterprise AI provider. The company views AI as a key driver for future growth, productivity enhancement, and cost savings for its enterprise clients.
  • Topaz Suite: Its proprietary AI stack, the Topaz suite, coupled with full-stack application services capabilities, is expected to be a crucial differentiator as clients increasingly scale their modernization and AI programs.

Stock Performance and Valuation

  • Market Underperformance: The Infosys stock has experienced a prolonged period of underperformance, being down more than 15 percent year-to-date. It has lagged behind not only the benchmark Nifty but also the broader IT Index.
  • Attractive Valuation: Currently, Infosys is trading at 22.7 times its estimated FY26 earnings, which represents a discount to its 5-year average valuation. Factors like the steady depreciation of the Indian currency and outflows of Foreign Institutional Investor (FII) funds are also noted.
  • Favorable Risk-Reward: Considering the current valuation and market conditions, analysts perceive the risk-reward profile for Infosys as having turned favorable, with expectations of limited downside despite the seasonally soft upcoming quarter (Q3).

Future Expectations

  • The company's strategic emphasis on AI is poised to capitalize on the growing demand for AI-led services.
  • Execution of large deals, especially the NHS contract, and the adoption of its Topaz suite will be critical for its future growth trajectory.

Impact

  • This news is significant for Infosys shareholders and the broader Indian IT sector, influencing investor sentiment and strategic decisions. The company's ability to leverage AI effectively will be closely watched.
  • Impact Rating: 7

Difficult Terms Explained

  • Constant Currency (CC): A financial reporting method that excludes the effects of foreign exchange rate fluctuations, providing a clearer view of underlying business performance.
  • Sequential Growth: Compares a company's performance from one reporting period to the immediately preceding period (e.g., Q2 FY26 compared to Q1 FY26).
  • Year-on-Year (YoY) Growth: Compares a company's performance over the same period in the previous year (e.g., Q2 FY26 compared to Q2 FY25).
  • Basis Points (bps): A unit of measure equal to one-hundredth of a percent (0.01%). Used to describe small changes in percentages, such as margin improvements.
  • FY26e: Refers to the estimated earnings for the Fiscal Year 2026.
  • FII (Foreign Institutional Investor): An overseas entity, such as a mutual fund or pension fund, that invests in securities in India.

No stocks found.


Startups/VC Sector

India's Startup Shockwave: Why Top Founders Are Exiting in 2025!

India's Startup Shockwave: Why Top Founders Are Exiting in 2025!

India's Investment Boom: PE/VC Hits 13-Month High in October, Surging Past $5 Billion!

India's Investment Boom: PE/VC Hits 13-Month High in October, Surging Past $5 Billion!


Healthcare/Biotech Sector

US FDA Inspects Ipca Labs API Plant: Key Observations Issued – What Investors Must Know NOW!

US FDA Inspects Ipca Labs API Plant: Key Observations Issued – What Investors Must Know NOW!

Massive ₹423 Crore Deal: Eris Lifesciences to Fully Own Swiss Parenterals!

Massive ₹423 Crore Deal: Eris Lifesciences to Fully Own Swiss Parenterals!

Pharma Deal Alert: PeakXV Exits La Renon, Creador & Siguler Guff Invest ₹800 Cr in Healthcare Major!

Pharma Deal Alert: PeakXV Exits La Renon, Creador & Siguler Guff Invest ₹800 Cr in Healthcare Major!

Healthify's Novo Nordisk Partnership Fuels Major Growth in Weight-Loss Market

Healthify's Novo Nordisk Partnership Fuels Major Growth in Weight-Loss Market

Indian Health-Tech Startup Healthify Partners with Novo Nordisk, Eyes Global Weight-Loss Drug Market Boom!

Indian Health-Tech Startup Healthify Partners with Novo Nordisk, Eyes Global Weight-Loss Drug Market Boom!

Pharma Giant Wins Major Court Battle: Landmark Ruling on Key Drug

Pharma Giant Wins Major Court Battle: Landmark Ruling on Key Drug

GET INSTANT STOCK ALERTS ON WHATSAPP FOR YOUR PORTFOLIO STOCKS
applegoogle
applegoogle

More from Tech

Crypto's Future Revealed: 2026 When AI & Stablecoins Will Forge a New Global Economy, VC Hashed Predicts!

Tech

Crypto's Future Revealed: 2026 When AI & Stablecoins Will Forge a New Global Economy, VC Hashed Predicts!

Microsoft Unleashes AI Future in India: Billions More for Data Centers & Elite Engineer Jobs!

Tech

Microsoft Unleashes AI Future in India: Billions More for Data Centers & Elite Engineer Jobs!

China's AI Chip Giant Moore Threads IPO EXPLODES Over 500% On Debut – Is This the Next Big Tech Boom?

Tech

China's AI Chip Giant Moore Threads IPO EXPLODES Over 500% On Debut – Is This the Next Big Tech Boom?

Apple Lures Meta Legal Chief Jennifer Newstead: iPhone Giant's Major Executive Overhaul!

Tech

Apple Lures Meta Legal Chief Jennifer Newstead: iPhone Giant's Major Executive Overhaul!

PhonePe's Pincode QUITS Quick Commerce! ONDC App Shifts Focus: What It Means for Indian Online Shopping

Tech

PhonePe's Pincode QUITS Quick Commerce! ONDC App Shifts Focus: What It Means for Indian Online Shopping

Apple's AI Pivot: Stock Hits Record High Amid Privacy-First Strategy Amidst Tech Race!

Tech

Apple's AI Pivot: Stock Hits Record High Amid Privacy-First Strategy Amidst Tech Race!


Latest News

SKF India's Bold New Chapter: Industrial Arm Lists, Unveils ₹8,000 Cr+ Investment!

Industrial Goods/Services

SKF India's Bold New Chapter: Industrial Arm Lists, Unveils ₹8,000 Cr+ Investment!

Fino Payments Bank's Major Leap: RBI Grants In-Principle Approval for Small Finance Bank Conversion!

Banking/Finance

Fino Payments Bank's Major Leap: RBI Grants In-Principle Approval for Small Finance Bank Conversion!

Shock Alert: India's Forex Reserves Plummet Billions! What This Means For Your Wallet

Economy

Shock Alert: India's Forex Reserves Plummet Billions! What This Means For Your Wallet

Fineotex Chemical Surges 6% on US Acquisition! Investor's Must-Know Details!

Chemicals

Fineotex Chemical Surges 6% on US Acquisition! Investor's Must-Know Details!

Bank of India Slashes Lending Rate: Borrowers Get Relief as RBI Move Triggers 25 Bps Cut!

Banking/Finance

Bank of India Slashes Lending Rate: Borrowers Get Relief as RBI Move Triggers 25 Bps Cut!

Hollywood's Biggest Blockbuster: Netflix Seals $72 Billion Deal for Warner Bros. Studios! Is This The End of an Era?

Media and Entertainment

Hollywood's Biggest Blockbuster: Netflix Seals $72 Billion Deal for Warner Bros. Studios! Is This The End of an Era?